GORDON L FLYNN
Pharmacy in Ann Arbor, MI
License number
Michigan 5304001544
Issued Date
May 18, 1992
Expiration Date
Jun 30, 2008
Category
Pharmacy
Type
CS - Research Lab
Address
Address
Ann Arbor, MI 48109
Personal information
See more information about GORDON L FLYNN at radaris.comName
Address
Phone
100 Michigan Ave, Charlevoix, MI 49720
2115 Nature Cove Ct APT 202, Ann Arbor, MI 48104
2115 Nature Cove Ct, Ann Arbor, MI 48104
Charlevoix, MI
Ann Arbor, MI
Professional information
Method For Increasing The Battery Life Of An Alternating Current Iontophoresis Device Using A Barrier-Modifying Agent
US Patent:
7137975, Nov 21, 2006
Filed:
Dec 10, 2001
Appl. No.:
10/014741
Inventors:
David J. Miller - Bountiful UT, US
William I. Higuchi - Salt Lake City UT, US
Kevin Li - Salt Lake City UT, US
Gordon L. Flynn - Ann Arbor MI, US
William I. Higuchi - Salt Lake City UT, US
Kevin Li - Salt Lake City UT, US
Gordon L. Flynn - Ann Arbor MI, US
Assignee:
Aciont, Inc. - Salt Lake City UT
International Classification:
A61M 31/00, A61N 1/30
US Classification:
604501, 604 20
Abstract:
An iontophoretic method for transporting compounds of interest across a body tissue is provided. The method utilizes an AC signal in conjunction with a barrier-modifying agent such as a fatty acid, fatty alcohol, bile acid, surfactant, or the like. The method enables the maintenance of a substantially constant electrical state in a localized region of the tissue through which transport occurs, thereby allowing a compound of interest to be transported across the tissue in a controlled and predictable manner. The barrier-modifying agent reduces the time as well as the voltage level required to achieve a target electrical resistance, thereby reducing patient discomfort and increasing the battery life of the iontophoresis device.
Apparatus For The Percutaneous Absorption Of Fluids
US Patent:
4863696, Sep 5, 1989
Filed:
Sep 12, 1988
Appl. No.:
7/244544
Inventors:
Michael E. Saydek - Somerville NJ
Gordon Flynn - Ann Arbor MI
Karlis Vizulis - Saline MI
Charles Von Reis - Ann Arbor MI
Gordon Flynn - Ann Arbor MI
Karlis Vizulis - Saline MI
Charles Von Reis - Ann Arbor MI
Assignee:
Crown Glass Company, Inc. - Somerville NJ
International Classification:
G01N 3348
US Classification:
422101
Abstract:
An orifice assembly for use in connection with diffusion cells for the percutaneous absorption of fluids which is composed of a pair of resiliant and mating members having structure for securely retaining a flexible membrane therebetween in a predetermined and fluid tight relationship with each other and the diffusion cells.
Ultrasound-Enhanced Delivery Of Materials Into And Through The Skin
US Patent:
5231975, Aug 3, 1993
Filed:
Mar 2, 1992
Appl. No.:
7/844732
Inventors:
Durairaj Bommannan - San Francisco CA
Hirohisa Okuyama - San Francisco CA
Richard H. Guy - San Francisco CA
Paul Stauffer - San Rafael CA
Gordon L. Flynn - Ann Arbor MI
Hirohisa Okuyama - San Francisco CA
Richard H. Guy - San Francisco CA
Paul Stauffer - San Rafael CA
Gordon L. Flynn - Ann Arbor MI
Assignee:
Cygnus Therapeutic Systems - Redwood City CA
Regents of the University of California - Oakland CA
Regents of the University of California - Oakland CA
International Classification:
A61B 1700, A61M 3700
US Classification:
128 24AA
Abstract:
A method for enhancing the permeability of the skin or other biological membrane to a material such as a drug is disclosed. In the method, the drug is delivered in conjunction with ultrasound having a frequency of above about 10 MHz. The method may also be used in conjunction with chemical permeation enhancers and/or with iontophoresis.
Ultrasound-Enhanced Delivery Of Materials Into And Through The Skin
US Patent:
5115805, May 26, 1992
Filed:
Feb 23, 1990
Appl. No.:
7/484560
Inventors:
Durairaj Bommannan - San Francisco CA
Hirohisa Okuyama - San Francisco CA
Richard H. Guy - San Francisco CA
Paul Stauffer - San Rafael CA
Gordon L. Flynn - Ann Arbor MI
Hirohisa Okuyama - San Francisco CA
Richard H. Guy - San Francisco CA
Paul Stauffer - San Rafael CA
Gordon L. Flynn - Ann Arbor MI
Assignee:
Cygnus Therapeutic Systems - Redwood City CA
The Regents of the University of California - Alameda CA
The Regents of the University of California - Alameda CA
International Classification:
A61B 1700, A61M 3700
US Classification:
128 24AA
Abstract:
A method for enhancing the permeability of the skin or other biological membrane to a material such as a drug is disclosed. In the method, the drug is delivered in conjunction with ultrasound having a frequency of above about 10 MHz. The method may also be used in conjunction with chemical permeation enhancers and/or with iontophoresis.
Ultrasound-Enhanced Delivery Of Materials Into And Through The Skin
US Patent:
5323769, Jun 28, 1994
Filed:
Aug 2, 1993
Appl. No.:
8/101491
Inventors:
Durairaj Bommannan - San Francisco CA
Hirohisa Okuyama - San Francisco CA
Richard H. Guy - San Francisco CA
Paul Stauffer - San Rafael CA
Gordon L. Flynn - Ann Arbor MI
Hirohisa Okuyama - San Francisco CA
Richard H. Guy - San Francisco CA
Paul Stauffer - San Rafael CA
Gordon L. Flynn - Ann Arbor MI
Assignee:
Cygnus Therapeutic Systems - Redwood City CA
The Regents of the University of California - Oakland CA
The Regents of the University of California - Oakland CA
International Classification:
A61B 1700, A16M 3700
US Classification:
601 2
Abstract:
A method for enhancing the permeability of the skin or other biological membrane to a material such as a drug is disclosed. In the method, the drug is delivered in conjunction with ultrasound having a frequency of above about 10 MHz. The method may also be used in conjunction with chemical permeation enhancers and/or with iontophoresis.
Compositions And Methods For Locally Treating Inflammatory Diseases
US Patent:
2001004, Nov 15, 2001
Filed:
Dec 1, 2000
Appl. No.:
09/728884
Inventors:
Timothy Laing - Ann Arbor MI, US
Gordon Flynn - Ann Arbor MI, US
Gordon Flynn - Ann Arbor MI, US
International Classification:
A61K031/47, A01N043/42
US Classification:
514/310000
Abstract:
Compositions and methods are provided for treating inflammatory diseases in mammals by inhibiting TNF expression. The methods comprise the step of topically administrating a composition of the present invention comprising thalidomide, N-alkyl analogs of thalidomide and combinations thereof.
Transdermal Delivery Of The Narcotic Analgesics Etorphine And Analogs
US Patent:
4891377, Jan 2, 1990
Filed:
Dec 2, 1988
Appl. No.:
7/278971
Inventors:
Charles Shipman - Dexter MI
Mohammad R. Nassiri - Ann Arbor MI
Gordon L. Flynn - Ann Arbor MI
Mohammad R. Nassiri - Ann Arbor MI
Gordon L. Flynn - Ann Arbor MI
Assignee:
Board of Regents Acting for and on behalf of University of Michigan - Ann Arbor MI
International Classification:
A61K 3144
US Classification:
514282
Abstract:
A process for relieving pain and novel topical compositions for transdermal delivery of a narcotic analgesic comprising the application to mammalian skin of an effective amount of a compound of the formula: ##STR1## or a pharmacologically acceptable acid addition salt thereof, where R is --CH. sub. 2, ##STR2## or --H and R' and R" are C. sub. 1 to C. sub. 6 hydrocarbons or --H, in association with a topical pharmaceutical carrier selected from the group consisting of ointments, lotions, pastes, jellies, gels, creams, sprays, aerosols and the like.
2-Acetylpyridine Thiosemicarbazone Compositions As Anitviral Agents
US Patent:
4777166, Oct 11, 1988
Filed:
Mar 31, 1986
Appl. No.:
6/846174
Inventors:
Sandra H. Smith - Ann Arbor MI
John C. Drach - Ann Arbor MI
Gordon L. Flynn - Ann Arbor MI
John C. Drach - Ann Arbor MI
Gordon L. Flynn - Ann Arbor MI
Assignee:
The United States of America as represented by the Secretary of the Army - Washington DC
The Regents of The University of Michigan - Ann Arbor MI
The Regents of The University of Michigan - Ann Arbor MI
International Classification:
A61K 3133, A61K 31395
US Classification:
514183
Abstract:
This invention relates to various compositions, comprising a 2-acetylprid thiosemicarbazone and a diol, which are useful in the treatment of viral infections.
Anti-Inflammatory Steroid
US Patent:
3980778, Sep 14, 1976
Filed:
May 20, 1975
Appl. No.:
5/579177
Inventors:
Donald E. Ayer - Kalamazoo MI
Carl A. Schlagel - Kalamazoo MI
Gordon L. Flynn - Ann Arbor MI
Carl A. Schlagel - Kalamazoo MI
Gordon L. Flynn - Ann Arbor MI
Assignee:
The Upjohn Company - Kalamazoo MI
International Classification:
A61K 3156
US Classification:
424243
Abstract:
The disclosure covers the preparation of the compound, 6. alpha. ,9. alpha. -difluoro-11. beta. ,17,21-trihydroxy-16. beta. -methylpregna -1,4-diene-3,20-dione 17. alpha. ,21-diacetate, (1) and methods and formulations for its anti-inflammatory use topically, orally and parenterally.
Topical Clindamycin Preparations
US Patent:
4018918, Apr 19, 1977
Filed:
Mar 19, 1976
Appl. No.:
5/668389
Inventors:
Donald E. Ayer - Kalamazoo MI
Carl A. Schlagel - Kalamazoo MI
Gordon L. Flynn - Ann Arbor MI
Carl A. Schlagel - Kalamazoo MI
Gordon L. Flynn - Ann Arbor MI
Assignee:
The Upjohn Company - Kalamazoo MI
International Classification:
A61K 3156
US Classification:
424240
Abstract:
Disclosed is an anti-inflammatory compound, 6. alpha. ,9. alpha. -di-fluoro-11. beta. ,17. alpha. ,21-trihydroxy-16. beta. -meth ylpregna-1,4-diene-3,20-dione 17,21-diacetate, and topical pharmaceutical formulations which include antimicrobial agents.